Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.71 |
| ▸ | CES1 | P23141 | 1/20 | 0.71 |
| ▸ | HPGD | P15428 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | MEN1 | O00255 | 1/20 | 0.59 |
| ▸ | EGFR | P00533 | 1/20 | 0.59 |
| ▸ | TP53 | P04637 | 1/20 | 0.59 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.59 |
| ▸ | PKM | P14618 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.59 |
| ▸ | JAK1 | P23458 | 1/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrogen Sulfide SCHEMBL29219474 | 0.98 | CES2 (0.68) | CES2CES1HPGDSMN1; SMN2KDM4E | |
| SCHEMBL3601971 | 0.93 | CES2 (0.61) | CES2CES1HPGDSMN1; SMN2KDM4E | |
| SCHEMBL29613672 | 0.83 | CES2 (0.74) | CES2CES1HPGDSMN1; SMN2KDM4E | |
| SCHEMBL30250451 | 0.83 | CES2 (0.74) | CES2CES1HPGDSMN1; SMN2KDM4E | |
| SCHEMBL941698 | 0.83 | CES2 (0.74) | CES2CES1HPGDSMN1; SMN2KDM4E | |
| SCHEMBL7220072 | 0.83 | CES2 (1.00) | CES2CES1HPGDSMN1; SMN2KDM4E | |
| SCHEMBL31032483 | 0.83 | CES2 (1.00) | CES2CES1HPGDSMN1; SMN2KDM4E | |
| SCHEMBL21817642 | 0.83 | ALDH1A1 (0.70) | CES2CES1HPGDKDM4EALDH1A1 | |
| Beta-Naphtoic Acid SCHEMBL29350891 | 0.82 | CES2 (0.65) | CES2CES1HPGDSMN1; SMN2KDM4E | |
| Beta-Naphtoic Acid SCHEMBL98296 | 0.81 | CES2 (0.71) | CES2CES1HPGDSMN1; SMN2KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1292 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9884882-B2 | Method for producing thiolane skeleton-type glycoconjugate, and thiolane skeleton-type glycoconjugate | FUJIFILM CORPORATION (JP) | 2018-02-06 | — | — | US | claimed |
| EP-3109245-B1 | METHOD FOR PRODUCTING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM CORP (JP) | 2018-01-03 | — | — | EP | claimed |
| EP-3109245-A1 | METHOD FOR PRODUCTING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM Corporation (JP) | 2016-12-28 | — | — | EP | claimed |
| US-20160355536-A1 | METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | FUJIFILM CORPORATION (JP) | 2016-12-08 | — | — | US | claimed |
| US-5597776-A | ANTAGONIST FOR HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1997-01-28 | — | — | US | claimed |
| EP-0537463-A2 | Substituted pyrido(2,3-d)pyrimidines as antidotes | BASF Aktiengesellschaft (DE) | 1993-04-21 | — | — | EP | claimed |
| EP-0180188-B1 | A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-04-15 | — | — | EP | claimed |
| US-3930866-A | MAGENTA | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | claimed |
| WO-2024150815-A1 | CEREBLON E3 LIGASE BINDING COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHOD THEREFOR | 田辺三菱製薬株式会社 | 2024-07-18 | — | — | WO | disclosed |
| US-20240239922-A1 | PHOTOCURABLE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-07-18 | — | — | US | disclosed |
| EP-3632441-B1 | METHOD FOR PRODUCING OPTICALLY ACTIVE COMPOUND | DAY ONE BIOPHARMACEUTICALS INC (US) | 2024-07-17 | — | — | EP | disclosed |
| CN-118344346-A | Heterocyclic compounds and their use | 武田药品工业株式会社 | 2024-07-16 | — | — | CN | disclosed |
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | ARVINAS OPERATIONS, INC. (US) | 2024-07-16 | — | — | US | disclosed |
| EP-3782986-B1 | HETEROCYCLIC COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2024-07-10 | — | — | EP | disclosed |
| US-3960571-A | 1-PHENYL-2-PYRAZOL-5-ONE MAGENTA COLOR FORMING COUPLER | Fuji Photo Film Co., Ltd. (JA) | 1976-06-01 | — | — | US | disclosed |
| US-3943153-A | BACTERICIDES | MERCK & CO., INC. (US) | 1976-03-09 | — | — | US | disclosed |
| US-3936462-A | CNS DEPRESSANT, ANALGESIC | STERLING DRUG INC. (US) | 1976-02-03 | — | — | US | disclosed |
| US-3935016-A | Silver halide color photographic materials containing 3-anilino-5-pyrazolone couplers | FUJI PHOTO FILM COMPANY, LTD. (JA) | 1976-01-27 | — | — | US | disclosed |
| US-3935015-A | Silver halide color photographic materials containing 3-anilino-5-pyrazolane couplers | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-27 | — | — | US | disclosed |
| US-3930866-A | MAGENTA | FUJI PHOTO FILM CO., LTD. (JA) | 1976-01-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12036209-B2 | Compounds and methods for the targeted degradation of Interleukin-1 receptor-associated kinase 4 polypeptides | IRAK1, IRAK4, IRAK2 | CES2 3781/4885CES1 2784/4885HPGD 3623/4885 |
| US-20160355536-A1 | METHOD FOR PRODUCING THIOLANE SKELETON-TYPE GLYCOCONJUGATE, AND THIOLANE SKELETON-TYPE GLYCOCONJUGATE | ST6GAL1, FUT6, FUT5 | CES2 699/4885CES1 921/4885HPGD 1321/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.